Brought to you by 
Nereus gets $23.6mm in private financing round
22 Mar 2002
Executive Summary
Nereus Pharmaceuticals (drugs from marine microorganisms to treat infectious diseases, cancer, and inflammation) completed a second round of financing, raising $23.6mm from lead investor Pacific Venture Group; new investors Novartis Bioventure, Blue Dot Capital, China Development Industrial Bank, Lotus Biosciences, and Swissfirst; and return investors Alta Partners, Forward Ventures, GIMV, Jafco, and Tech Amp International.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Molecular Diversity
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Nereus gets $23.6mm in private financing round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice